New self-expanding heart stent from Biotronik proves effective in clinical trial
A new metallic peripheral stent from Berlin, Germany-based Biotronik was proved effective in new research presented at VEITHsymposium 2016, a cardiology conference in New York.
Biotronik’s Pulsar-18 is a bare metal self-expanding stent, which is designed to treat superficial femoral artery disease. A study on the device was led by Michael Lichtenberg, MD, an interventional cardiologist in Arnsberg, Germany, according to a statement from Biotronik.
Pulsar-18 is created with silicon carbide coating that is meant to reduce metal ion release from the stent into surrounding tissues. It is available it diameters of four to seven mm, all deliverable through a 4 F sheath.
Twelve-month study results show that the stent is effective with a clinical success rate of 85 percent.
“It is reassuring to see that the clinical outcomes in this real world registry are similar to already published 12-month data,” said Jos C. van den Berg, an author on the study, in a statement. “These positive results were obtained with the Pulsar stent, which has a thin strut design producing a low chronic outward force (COF). As higher COF has been shown to result in higher restenosis rates, Pulsar’s unique design can be combined with minimal oversizing to further reduce COF for better outcomes.”
Senior Writer
As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.